where specialists connect on complex cases

Psoriasis, Psoriatic Arthritis,
Rheumatoid Arthritis,
Crohn’s Disease, and
Ulcerative Colitis


Thank you to everyone who participated in the IAS Meeting 2018!

Join us next year, April 5-7, 2019 in Chicago, IL.

Optimizing Interdisciplinary Care for the Management of Immune-Mediated Inflammatory Diseases

IAS 2018 is the only event of its kind that brings together rheumatologists, dermatologists, gastroenterologists, immunologists, internists, and other HCPs to debate, discuss, and collaborate on optimal treatment strategies for immune-mediated inflammatory diseases (IMIDs).

Attend IAS. Register Today.


For three days, share strategies with the very best minds in the field, embrace innovation, and learn about the vital role emerging therapies play in the treatment of patients with immune-mediated inflammatory diseases (IMIDs) such as:





CROHN'S DISEASE AND Ulcerative Colitis

Senior Advisors

Leonard H. Calabrese


Professor of Medicine
Cleveland Clinic Lerner
College of Medicine
Case Western Reserve University
Cleveland, Ohio

Joel M. Gelfand


Professor of Dermatology and Epidemiology
Perelman School of Medicine
Univeristy of Pennsylvania
Philadelphia, Pennsylvania

Stephen B. Hanauer


Clifford Joseph Barborka
Professor of Medicine
Northwestern University
Chicago, Illinois


Adam S. Cheifetz


Director, Center for Inflammatory Bowel Disease
Beth Israel Deaconess Medical Center
Associate Professor of Medicine
Harvard Medical School

Joseph F. Merola


Assistant Professor
Harvard Medical School

Mital Patel


Director, Hidradenitis Suppurativa and Neutrophilic Dermatoses Clinic
Assistant Program Director, Dermatology and Rheumatology Fellowship
Instructor in Dermatology, Harvard Medical School
Associate Physician, Brigham and Women’s Hospital, Department of Dermatology

We each care for patients, teach, and conduct research in a specific, discipline-focused universe. When we come together to listen to, converse with, and understand the perspectives of experts from other medical disciplines within the autoimmune disease field, the boundaries of our knowledge are expanded, which in turn enriches our research, teaching, and care of patients.

Philip J. Mease, MD

Clinical Professor of Medicine, University of Washington School of Medicine, Director of Rheumatology Clinical Research, Swedish Medical Center, Seattle Rheumatology Associates

There’s a growing realization that inflammatory diseases are not linked to any one organ system. So many specialties are involved, and each has insights. I first joined IAS because I am excited to learn from colleagues in other specialties. I keep coming back because of the new insights I gain each time I attend the IAS meeting.

Steven R. Feldman, MD, PhD

Wake Forest University School of Medicine, Professor of Dermatology, Pathology, and Public Health Sciences

IAS speakers were excellent and the quality of the presentations were outstanding. I will definitely attend every year!

Paul S. Yamauchi, MD, PhD

Clinical Assistant Professor of Dermatology, David Geffen School of Medicine at UCLA, Adjunct Associate Professor, John Wayne Cancer Institute, Dermatology Institute & Skin Care Center, Inc., Clinical Science Institute

previous next

Recent News

Q&A with Mital Patel, MD

Thursday, March 22, 2018 - 16:31

Lisa B. Samalonis, Managing Editor

Dr Patel is director, Hidradenitis Suppurativa and Neutrophilic Dermatoses Clinic; assistant program director, Dermatology and Rheumatology Fellowship; instructor in...

Read more

The Future of Immune-mediated Inflammatory Diseases

Friday, March 16, 2018 - 10:37


Lisa B. Samalonis, Managing Editor

Read more

Keep Me Informed

Sign up for news alerts

13 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Contact Us

2 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.